The genomic region coding for the antigenic structure responsible for the induction of neutralizing antibodies was localized in the central variable region of the VP2 gene by comparing the nucleotide sequence of five escape mutants derived from the standard infectious bursal disease virus strain Cu-1. Exchange of a single amino acid at one of the prominent hydrophilic parts of this region proved to be sufficient for altering the neutralizing properties. The reactivity of neutralizing antibodies with peptides expressed in vitro encompassing both hydrophilic areas suggests that the entire variable region is engaged in the formation of this conformationdependent antigenic site. VP2-specific, non-neutralizing monoclonal antibodies directed against the sequencedependent epitope of the serotype I strain Cu-1 and the serotype II strain 23/82 cross-reacted with peptides located towards the carboxy terminus of VP2; no reaction occurred with peptides derived from the aminoterminal side adjacent to the variable region.
Introduction
The antigenic site responsible for the induction of neutralizing antibodies against infectious bursal disease virus (IBDV), a member of the family Birnaviridae, has been located on VP2 (M r 40K), one of the two major structural proteins of the virus (Azad et al., 1987; Becht et aL, 1988) . Identification of this antigenic domain has implications for the control of infectious bursal disease, because stimulation of neutralizing antibodies is decisive for the establishment of a protective immunity (Cursiefen et al., 1979) .
There have been conflicting reports about the role played by the second major structural protein VP3 (Mr 32K) in the induction of neutralizing antibodies (Fahey et al., 1985; Azad et al., 1986) ; however, there is general agreement now that a conformation-dependent epitope located on VP2 represents the immunodominant determinant (Azad et al., 1987; Becht et al., 1988; Fahey et al., 1989) . Binding of neutralizing monoclonal antibodies (MAbs) to fusion proteins produced by expression systems carrying stepwise truncated VP2 genes indicated that the genetic information for this antigenic domain is located in the central region of the VP2 gene (Azad et al., 1987) . This conformational epitope reacting with neutralizing antibodies gained additional significance
The nucleotide sequence data reported in this paper were submitted to the EMBL nucleotide sequence database and assigned the accession numbers Z21971 for strain 23/82 and X16107 for strain Cu-1. when antigenic variations of IBDV strains isolated in the U.S.A. were held responsible for vaccination failures (Rosenberger et al., 1985; Snyder et al., 1988) . Comparison of the nucleotide sequence of the VP2 gene in an American variant with the known sequence of standard strains revealed changes in amino acids in the central region of the VP2 gene (Heine et al., 1991) .
For a precise definition of the epitope capable of inducing neutralizing antibodies we have used five escape mutants which had been selected for their capacity to circumvent neutralization. Serological analysis had suggested that the variable epitopes are spaced closely adjacent to each other (Oppling et al., 1991) . Since these mutants are immediate derivatives of the wild-type virus, a comparison of the nucleotide sequence of the VP2 genes could be expected to refer specifically to the generation of the epitope in question. Since the induction of neutralizing antibodies depends on the conformation of the antigenic site (Becht et al., 1988) , the procedure of precipitation of in vitro translation products by neutralizing antibodies in a eukaryotic system was employed in order to determine the significance of the varied nucleotide sequences on epitope structure.
In addition to IBDV strains causing the economically important infectious bursitis in chickens, a non-pathogenic second serotype had been isolated from turkeys which can be differentiated from standard serotype I IBDV by neutralization (Chettle et al., 1985) . Apart from this definite difference in antigenic structure of VP2 there is a sequence-dependent epitope on this structural protein which both serotypes have in common (Becht et al., D. Schnitzler and others 1988) . A second goal of this study was, therefore, to map the region on the VP2 gene which codes for this antigenic structure common to both serotypes.
Methods
Virus and antibodies. IBDV strain Cu-1 (Nick et al., 1976 ) was used as a representative of serotype I. Chick embryo cells were inoculated at a low m.o.i. After the appearance of a c.p.e, about 20 h after infection virus was harvested and purified by centrifugation in CsCI gradients (Miiller & Becht, 1982) .
Preparation and the serological properties of five escape mutants were described previously (0ppling et al., 1991) . These mutants had been selected in the presence of a neutralizing MAb in the agar overlay of a plaque assay. Among the panel of neutralizing antibodies available three groups of selection barriers emerged. The reaction patterns are summarized in Table 1 . Escape mutants EM401 and EM300 had been produced in a further step of selection from strains EM8 and EM124 with a second neutralizing MAb. Virus yields among the mutants and the wild-type virus did not differ by more than 10-fold when measured by plaque assay. The neutralizing MAbs listed in Table 1 were also used for immunoprecipitation in this study.
The turkey isolate 23/82 (Chettle et aL, 1985) is a representative of serotype II of IBDV and had been kindly provided by N. E. Reed, Central Veterinary Laboratory, Weybridge, U.K.
For the generation of VP2-specific cross-reacting MAbs a mouse was immunized intraperitoneally with purified whole virus particles of serotype II strain 23/82 suspended in aluminum hydroxide; a second mouse was immunized with VP2/VP2a of serotype I strain Cu-1 which had been electroeluted from a 12.5 % polyacrylamide gel. Fusion with Sp2/0 myeloma cells was carried out according to standard procedures (Fazekas de St. Groth & Scheidegger, 1980; Lane, 1985) . Production of antibodies was monitored by ELISA; hybridomas secreting VP2-specific cross-reacting antibodies were selected by immunoblotting. Reciprocal reactions of the two MAbs used in this study are documented in Fig. 1 . For large-scale production of MAbs hybridomas were incubated in IMDM-medium containing 10 % horse serum for 1 week, and antibodies were purified by antiglobulin-mediated affinity chromatography.
Sequencing of the VP2 gene after amplification by PCR. Genomic dsRNA was isolated from purified virus preparations by treatment with proteinase K and SDS, extraction with phenol/chloroform and precipitation with ethanol, dsRNA was prepared for reverse transcription by heating at 95 °C followed by rapid freezing in liquid nitrogen. The denatured RNA was kept on ice until the reaction was started. Reverse transcription and PCR followed standard protocols (Saiki et al., 1988) , using the GeneAmp RNA PCR Kit supplied by (1990) and Innis & Gelfand (1990) and were provided by H. Hegemann, Giessen. The forward primer for reverse transcription and PCR corresponded to base pairs 65 to 82 upstream of the initiation codon of the VP2 gene, and the backward primer covered the positions 1473 to 1456 in the VP4 gene immediately adjacent to the VP2 region. These numbers of base pairs correspond to the positions proposed by Spies et al. (1989) and Hudson et al. (1986) . For the sequencing reactions two additional pairs of primers were chosen: no. 681 to 702 and 1217 to 1196; 306 to 327 and 811 to 790. In some experiments asymmetric PCR was employed (lnnis et al., 1988; Innis & Gelfand, 1990) . Positive controls contained eDNA spanning the entire VP2 gene of wild-type Cu-1 (Spies et al., 1989; Bayliss et al., 1990) .
Thirty-five cycles of PCR were started in an automated thermal cycler by heating the reaction mixture at 95 °C for 2 rain, followed by annealing for 2 min at temperatures between 50 °C and 70 °C according to the primers and extension at 72 °C for 3 min. The final extension step was lengthened to 20 min.
Amplification products were extracted with chloroform, and 10 gl from a total volume of 100 ~tl was analysed by electrophoresis in 1% agarose/ethidium bromide gels. ~ DNA-BstEII digest (New England Biolabs) was used as size standards. DNA species of interest were excised and purified on a silicon matrix (Geneclean Kit; Bit Incorporated).
Cloning and sequencing of PCR products. Amplification products were digested with XbaI and HindII and ligated into the linearized vector pUC19 (New England Biolabs). Escherichia coli XLl-blue was made competent and transfected with plasmid DNA as described by Dagert & Ehrlich (1979) . Double-stranded DNA fragments generated by PCR and denatured by heating and rapid freezing were sequenced directly by the dideoxynucleotide chain termination method (Sanger et al., 1977) using the T7 Sequencing Kit (Pharmacia). One primer of each of the three pairs listed above was cmployed in the sequencing reaction which was carried out according to the supplier's instructions. Reaction products were separated in 6 % polyacrylamide gels containing 8 M-urea at 55 °C. Sequence data were aligned by the computer program DNASIS (Pharmacia). As an alternative technique sequences inserted into the pUC vector were determined as described (Spies et al., 1989) . This protocol and the asymmetric PCR technique confirmed the results obtained by direct PCR sequencing.
In vitro transcription/translation. RNA synthesis was based on the procedure outlined by Melton et al. (1984) and Sambrook et al. (1989) . The forward primers used in PCR experiments intended for the production of eDNA for in vitro transcription/translation contained the sequences for the GC linker, a XbaI cleavage site, T3 promoter followed by the virus-specific nucleotides; the backward primer was constructed as the GC linker, the HindIII recognition site and the virusspecific sequence. The cDNA amplified by PCR and the vector pUC19 were cleaved by the endonucleases XbaI and HindIII, and the resulting fragments were separated electrophoretically. After ligation, the vector carrying the inserts was replicated in E. eoli XLl-blue, the plasmid was isolated and linearized by cleavage with HindIIL This cleavage site served as terminus for the production of virus-specific mRNA. Nucleotide sequencing of both ends of the amplified DNA verified that the required virus-specific DNA fragments were available. The linearized plasmid DNA was introduced into a commercial transcription kit (TransProbe T Kit, Pharmacia). Two reaction mixtures which had received 0"5 to 1 gg linearized plasmid DNA were run in parallel. Instead of the capping solution and UTP one assay received [35S] UTP (Amersham). After 30 min at 37 °C the DNA was destroyed by the addition of DNase I, mRNA was extracted by phenol/ chloroform, washed with ethanol, vacuum-dried and dissolved in 10 gl of RNase-free water. Labelled RNA transcripts were identified after dilutions 1 : 1 with formamide/EDTA sample buffer and electrophoresis under denaturing conditions in a 6 % polyacrylamide gel.
For in vitro translation the procedure described by Krieg & Melton (1984) was slightly modified. Capped RNA transcripts were heated at 67 °C for 10 rain and translated in a rabbit reticulocyte translation system (Promega). The reaction mixture containing 25 laCi L-[3SS]methionine or L-[35S]cysteine was incubated for 1 h at 30 °C. One half of the reaction product was analysed directly by PAGE, the other half was immunoprecipitated (Mfiller & Becht, 1982) , and the precipitate was analysed in 15 % polyacrylamide gels. The labelled precipitates were located by fiuorography. 14C-labelled proteins (Amersham) were used as markers.
Immunoblots. Purified virus was dissociated in sample buffer, viral
proteins were separated in a 15 % polyacrylamide gel and transferred by the semi-dry blotting procedure to an Immobilon membrane (Millipore). Antibody binding was visualized by treatment with biotinylated antiglobulin and streptavidin peroxidase.
Results

Preparation of cDNA of the VP2 gene
Reverse transcription starting with primers that flanked the entire coding sequence o f the VP2 gene yielded a c D N A which could be amplified by P C R . (Spies et al., 1989; Bayliss et al., 1990) . This P C R amplification p r o d u c t furnished the template for the direct establishment of the nucleotide sequence o f the five escape m u t a n t s and o f the serotype II strain 23/82. AccI-SpeI fragment was position bp 662 which contained silent mutations in two strains (Fig. 2) . It should be noted here that the restriction site SpeI, which had been introduced previously (Bayliss et al., 1990) , was retained here as a point of comparative orientation, although base position 1145 is occupied by a G instead of A in other IBDV strains. Table 2 and Fig. 2 show that the number of bases which had been modified are 1, 2 or 3. Three exchanges occurred in the two escape mutants which had been selected by a further growth step in the presence of a second neutralizing antibody from EM8 and EM124. During this two-step selection not all base changes from the first stage of selection were preserved; in these cases the generation of a functional gene required the reversion of one base to the wild-type sequence. The changed amino acids (Fig. 2) are clustered in the two prominent hydrophilic regions (amino acids 212 to 224 and 314 to 324), designated A and B in Fig. 3 , in accordance with the hydrophilic profile published by Bayliss et al. (1990) and Heine et al. (1991) . This set of variations is particularly evident for the carboxy-terminal side where all changes are grouped as one block (area B), whereas at the amino-terminal side the diversifications are not as tightly spaced (area A).
Nucleotide sequence of the VP2 genes of escape mutants
The significance of the observed mutations for the formation of hydrophilic sites was evaluated further by estimating the difference in hydrophilicity between escape mutants and wild-type virus by applying the parameters of Kyte & Doolittle (1982) and the HUSAR package of GENIUS net service of the German Cancer Research Center, Heidelberg, Germany. With the exception of EM200 which remained virtually unaltered, all mutations resulted in an increase in hydrophilicity at the sites of the exchanged residues.
An opposite tendency became apparent when the hydrophilicity plots of VP2 of both serotypes were compared. In the profile outlined in Fig. 3 the hydrophilic region B of the serotype II strain 23/82 had virtually disappeared, obviously as a consequence of the exchange of four amino acids (see below). Juxtaposition of all amino acids of the VP2 polypeptides of both serotypes demonstrates that again the bulk of diversification is clustered in the central variable region (Fig. 6) .
Mapping of VP2 antigenic domains by in vitro translation and immunoprecipitation
Primers were constructed for the polymerase T3-mediated transcription of the central variable region of the VP2 gene and the two halves of this AccI-SpeI domain:primers 657 to 680 and 1217 to 1149 spanning the entire AccI-SpeI region, 657 to 680 and 904 to 881 adjacent to the AccI site, 883 to 906 and 1217 to 1194 at the opposite side adjacent to SpeI. After amplification of these fragments by PCR and cloning into pUC19, the three species of mRNA corresponding to these fragments were efficiently transcribed from the linearized DNA (Fig. 4) and could be introduced into the in vitro translation system. The translation reactions produced peptides of the expected M r which could be demonstrated with samples labelled with [3SS]methionine; [aSS] cysteine was used for labelling peptides at the amino-terminal half that did not contain a sufficient amount of methionine residues (data not shown). The immunoprecipitates formed after the reaction of neutralizing antibodies with in vitro translation products generated from the escape mutants EM8, EM124 and EM200 can be grouped into three reaction patterns. Precipitates were formed by the reaction of all antibodies with the entire AccI-SpeI translation product of all three mutant strains (amino acids 193 to 374; Fig.  5 a, b, c) . In Fig. 5(a) , however, no reaction is visible with either half of the variable region of EM8. In the reaction type of Fig. 5(b) only the second half (amino acids 290 to 374) of EM 124 was recognized by antibodies, whereas no signal can be detected on the gel where the first half (amino acids 193 to 269) should have appeared. In the case of EM200 the reaction pattern of Fig. 5(c) demonstrates that the fragments on either side can be recognized by antibodies (Mr 8"5K for the first half and 9.4K for the second half). This is the escape mutant that only had a single mutation resulting in the transition of threonine to proline ( Table 2 ). The reaction products belonging to the second half were always discernible as a double band; no obvious explanation is available for the reproducible formation of these two bands. It is remarkable that in each case the selecting MAb, which is not capable of neutralizing the respective mutant, recognized the in vitro translation products.
Mapping of the cross-reacting epitopes
When it had become clear that the antigenic site responsible for the induction of neutralizing antibodies must be confined to the central region of VP2, the adjacent regions in both directions were candidates for the cross-reacting antigenic site in question. As a first step to clarify this topography, the nucleotide sequence of the VP2 gene of serotype II had to be established (see accession number for the nucleotide sequence of the genomic segment A of strain 23/82). The nucleotide sequences of the VP2 gene of the serotype II strain 23/82 and serotype I Cu-1 were aligned to yield maximal sequence homologies. Under this condition an additional C is located at the 5' end in position 20 of strain Cu-1, and three nucleotides are missing in positions 841 to 843 of the same strain. In this alignment the reading frames are conserved; the small open reading frame (ORF) starts with its initiation codon in position 64 and the large ORF in position 98. In both strains the AccI restriction site is conserved (Bayliss et al., 1990) between nucleotides 710 and 715, whereas the SpeI site is not in either case.
It is evident from Fig. 6 that a total of seven amino acids, which are distributed throughout the aminoterminal side adjacent to the variable region, do not match along this segment. At the carboxy-terminal side, however, there is complete homology in the amino acid sequence. Consequently, the forward primer starting this to 8 contain the entire AccI-SpeI region, lanes 9 to 12 the half adjacent to the AccI site and lanes 13 to 16 the half adjacent to the SpeI site. For precipitation polyclonal rabbit antibodies directed against Cu-1 wildtype particles were used in lanes 1, 5, 9, and 13; MAbs used were 1/A6 in lanes 2, 6, and 14, 14/B5 in lanes 3, 7, 11 and 15, and 4/B4 in lanes 4, 8, 12 and 16, respectively . The arrows indicate the M r of the translated products (20-2K, left; 9-4K right; 8'5K, lower left in c). In vitro translation and precipitation were carried out as for Fig. 5 . Precipitated translation products from the nucleotides adjacent to the AccI site were run in lanes 1 to 3, those adjacent to the SpeI site in lanes 4 to 6. Negative controls in lanes 7 to 9. The 35S-labelled products precipitated with polyclonal rabbit antibodies directed against Cu-1 wild-type particles were applied to lanes 1, 4 and 7; those precipitated by the cross-reacting serotype I-specific MAb II40/D6 to lanes 2, 5 and 8; those precipitated by the serotype II-specific MAb T78 to lanes 3, 6 and 9. The arrow indicates the position of a product with an expected M r of 6-8K.
common region was positioned here (nucleotides 1266 to 1286). For both serotypes clones were constructed at either side of VP2 similar to the procedures described for the central variable region. After in vitro expression and immunoprecipitation only a translation product with the expected M r of 6"8K reacted with the cross-reacting MAbs (Fig. 7 a, lanes 1 to 3; 7 b lanes 4 to 6); analogous signals could not be detected with translation products of the amino-terminal side. Although the precipitate discernible with strain Cu-1 (Fig. 7a ) is quite faint, it was reproducibly found in the 6.8K position. The bands in the upper part of the gels must be interpreted as nonspecific, since they also appeared in normal serum controls.
Discussion
Comparative nucleotide sequencing of escape mutants of IBDV which had been selected from the wild-type virus by neutralizing MAbs localized point mutations for each mutant within a limited region of the VP2 gene which had previously been designated as variable by comparing the genomes of several standard strains (Bayliss et al., 1990 ) without reference to their antigenic structure. Analysis of escape mutants minimized the chance that this type of strain variation blurred the antigenic map. The identity of sequences flanking either side of the central variable region supported previous evidence that this variable region dominates the formation of epitopes which are responsible for the induction of neutralizing antibodies (Azad et al., 1987; Heine et al., 1991) . Two prominent hydrophilic areas in the variable region harbour the exchanged amino acids. The tendency of the mutations to increase the hydrophilicity of these areas underlines their immunodominant role. The relative significance of the two symmetrically spaced hydrophilic areas A and B (Fig. 3) for the formation of an epitope seems to be equivalent, since separately formed polypeptides of both halves of the variable region were recognized by antibodies. Correspondingly, mutations concerning one or the other side could abolish the synthesis of polypeptides which were capable of binding antibodies. These findings suggest that the entire variable region is engaged in the establishment of an antigenic domain which furnishes the basic structure for the induction of neutralizing antibodies. The effect of the slightest structural discrepancy in the hydrophilic area became evident by the finding that in one of the escape mutants a single mutation, which resulted in the replacement of a proline by a threonine, was sufficient to alter the specificity of the epitope, which is reminiscent of an 'antigenic drift' in orthomyxoviruses. This conclusion becomes particularly pertinent if one considers area B of the hydrophilicity plot for strain 23/82 where the establishment of a different serotype is accompanied by a loss of explicit hydrophilic properties (Fig. 3) . A mismatch of four amino acids in this fragment seems to be the essential reason for this 'antigenic shift'.
A comparison of the two blocks encompassing the exchanged nucleotides (Fig. 2) with the variability of sequences in the central regions of the classic serotype I strains (Bayliss et al., 1990) shows the relative significance of the hydrophobic fragment linking the hydrophilic regions A and B. This segment seems to tolerate a certain variation of amino acid sequences within a given serotype without explicit consequences for antigenic properties or replication of the virus.
A general concept for the antigenic diversity of IBDV seems to emerge from this discussion and the data available so far. Exchange of one amino acid in the hydrophilic areas A and B is the motif for an antigenic drift; more exchanges in A and B may lead to the establishment of a serotype I variant strain (Heine et al.,  1991) , and replacement of four amino acids with a concomitant loss of hydrophilicity in A and particularly in B (Fig. 3) can generate a new serotype. A salient feature of the reactivity of antibodies and the variable region expressed in vitro is the reactivity of peptides originating from escape mutants with antibodies used for their selection which are no longer neutralizing the homologous escape mutant. This finding underlines the significance of the strict conformation-dependence of neutralization (Becht et al., 1998) . In order to realize the fine specificity of this reaction, the epitope must be part of the whole protein.
The structural basis for the antigenic determinant which could be recognized as common for the crossreactive antibodies is realized by the sequence homology of the carboxy-terminal side adjacent to the variable region and limited by the VP4 gene. The immediate vicinity of this highly conserved segment to the hypervariable region on VP2 is one of the astonishing properties of the architecture of IBDV. According to the sequence published for segment A of the serotype II strain OH (Kibenge et al., 1991) this feature seems to be a general characteristic of the VP2 protein. A final judgement about the potentials of the amino-terminal side for epitope formation must await appropriate MAbs or antipeptide sera development. If an epitope exists at this site, one is inclined to suspect its serotype-specificity in view of the numerous disparities in the amino acid sequence of this region (see Fig. 6 ).
